"Designing Growth Strategies is in our DNA"

Nanopharmaceuticals Market Size, Share & Industry Analysis, By Type (Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion, Nanoemulsion, Others), By Application (Cancer, Autoimmune Disorders, Inflammation, Others) and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI101873 | Status : Ongoing

 

KEY MARKET INSIGHTS

Nanopharmaceuticals has proven to be boon to the pharmaceutical R&D and in the treatment of complex disorders. Nanotechnology can be strategically implemented in the drug delivery systems that can drastically expand the drug market in the coming years. Nanopharmaceuticals helps in the easy detection of the disease in the early stage and thus help in the early treatment of the diseases. Nanopharmaceuticals have tremendous potential in attributing the failure of traditional therapeutics. Pharmaceutical industries are facing enormous problems in delivering effective treatment for complex diseases and are striving hard to apply nanotechnology for drug delivery and drug discovery. This huge market potential of nanotechnology in combination with drugs for the pharmaceutical companies is anticipated to propel the nanopharmaceuticals market growth during the forecast period.


Various advantages of nanotechnology in drug delivery over other therapeutics such as faster delivery, early detection, and higher efficiency are responsible to drive the nanopharmaceuticals market during the forecast period. Additionally, increasing R & D by pharmaceutical and biotechnology companies in discovering novel drugs, growing investments in nanopharmaceuticals, and prevalence of neurological disorders & cancer is expected to drive the market growth.


Key Market Driver -

Huge market potential for pharmaceutical companies in nanotechnology for development of effective therapeutics

Key Market Restraint -

High R & D expenditure for drug discovery


However, the high investments associated with drug development in nanopharmaceuticals are likely to hinder the market growth during the forecast period. Also, the lack of regulatory guidelines and toxicity issues associated with nanotechnology are anticipated to affect the global nanopharmaceuticals market growth.


Key Players Covered:


The major companies covered in the nanopharmaceuticals market report include Eli Lilly and Company, Merck & Co., Inc., Pfizer Inc, Abbott, AstraZeneca, Johnson & Johnson Services, Inc. F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, and others.


As per the current global nanopharmaceuticals market trend, cancer in the application segment accounts for the highest share in terms of revenue owing to the demand for early detection and effective treatment for cancer and tumor disorders.


Key Insights:



  • Prevalence of cancer – For key countries, 2018

  • Overview of nanopharmaceuticals industry trends

  • Pipeline analysis

  • New product launch

  • Key mergers and acquisitions


Regional Analysis:


Geographically, the global nanopharmaceuticals market is segmented in North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is the leading region in terms of revenue owing to rapid R & D by the pharmaceuticals in the development of novel drugs, the presence of major players, and higher prevalence of cancer in the region. Europe accounts for the second position in the global market owing to advancements in the healthcare industry and focuses on the development of novel drugs using nanotechnology.


To gain extensive insights into the market, Request for Customization


The market in Asia Pacific is also expected to grow at a significant CAGR during the forecast period due to the growing prevalence of cancer and demand for effective treatment, rapid technological advancements, etc. Latin America is expected to account for a comparatively smaller share owing to growing awareness pf nanopharmaceuticals and the need for the development of novel drugs in the treatment of cancer and other complex disorders. Middle East & Africa is expected to witness a restricted growth due to lack of awareness and lesser technological advancements in the region.


Segmentation






















 ATTRIBUTE


 DETAILS

By Type




  • Liposomes

  • Polymeric Micelles

  • Solid Lipid Nanoparticles

  • Microemulsion

  • Nanoemulsion

  • Others



By Application




  • Cancer

  • Autoimmune Disorders

  • Inflammation

  • Others



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Nanopharmaceuticals Industry Developments



  • In February 2019, Nanogen Labs, Inc., a nano-emulsion company, announced the launch of nanoE to enhance the water compatibility and bioavailability of cannabinoids.

  • In July 2018, Ocugen, Inc. launched phase-3 clinical trial for OCU300 nanoemulsion, designed to treat ocular graft versus host diseases.


Nanopharmaceuticals Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Johnson
abbvie
Siemens Healthineers
Ipsos
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X